$ARWR· SEC filing ·

ARWR Reports $53.4M Revenue, $0.58 EPS, REDEMPLO Exceeds 400 Total Prescriptions, +40% Growth in 4 Weeks

Arrowhead Research Corporation · PHARMACEUTICAL PREPARATIONS · Now $75.20

-6.7% in 1d after detection

Post-detection moves

1h
1d
-6.7%
3d
+1.4%
7d
-5.1%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS